Non-alcoholic fatty liver disease primary prevention
|
Non-Alcoholic Fatty Liver Disease Microchapters |
|
Differentiating Non-Alcoholic Fatty Liver Disease from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case studies |
|
Non-alcoholic fatty liver disease primary prevention On the Web |
|
American Roentgen Ray Society Images of Non-alcoholic fatty liver disease primary prevention |
|
Non-alcoholic fatty liver disease primary prevention in the news |
|
Blogs on Non-alcoholic fatty liver disease primary prevention |
|
Directions to Hospitals Treating Non-alcoholic fatty liver disease |
|
Risk calculators and risk factors for Non-alcoholic fatty liver disease primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S [2] Parth Vikram Singh, MBBS[3]
Overview
Measures that may reduce MASLD development or progression include maintaining a healthy weight, reducing excess caloric intake, limiting ultraprocessed foods, saturated fats, refined sugars, and sugar-sweetened beverages, engaging in regular physical activity, avoiding alcohol intake, and effectively managing type 2 diabetes, obesity, dyslipidemia, and hypertension.
Primary Prevention
Effective measures for the primary prevention of non-alcoholic fatty liver disease include:
- Eating a healthy diet that is rich in vegetables, fruits and healthy fats is the first and very important step.[1][2]
- Regular exercise
- Maintaining a healthy weight
- Alcohol cessation
- Compliant with medications
- Patients must also be immunized for hepatitis A and B.
References
- ↑ Patil R, Sood GK (2017). "Non-alcoholic fatty liver disease and cardiovascular risk". World J Gastrointest Pathophysiol. 8 (2): 51–58. doi:10.4291/wjgp.v8.i2.51. PMC 5437502. PMID 28573067.
- ↑ Tilg H, Petta S, Stefan N, Targher G (January 2026). "Metabolic Dysfunction-Associated Steatotic Liver Disease in Adults: A Review". JAMA. 335 (2): 163–174. doi:10.1001/jama.2025.19615. PMID 41212550 Check
|pmid=value (help).